Global Medical REIT Inc. Announces Retirement of Ronald Marston from its Board of Directors and Declares 2025 Fourth Quarter Common and Preferred Dividends Share BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the "Company†or "GMRE†) today announced that Ronald Marston has notified the Board of Directors (the "Board†) that he plans to retire as a member of the Board at the end of his current term and that the Board has declared the Company's 2025 fourth quarter common and preferre ...

Core Viewpoint - Global Medical REIT Inc. has announced a proposed public offering of its Series B Cumulative Redeemable Preferred Stock, aiming to utilize the net proceeds for general corporate purposes, including funding new acquisitions and repaying debt [1][3]. Offering Details - The offering will include a 30-day option for underwriters to purchase additional shares to cover over-allotments [1]. - The Series B Preferred Stock is intended to be listed on the New York Stock Exchange under the ticker symbol "GMRE-PrB" [2]. - The offering is made under the company's shelf registration statement, which was declared effective by the SEC on April 4, 2024 [3]. Use of Proceeds - The net proceeds from the offering are expected to be used for general corporate purposes, which may include funding new acquisitions and repaying existing indebtedness [1]. Company Overview - Global Medical REIT Inc. operates as a net-lease medical REIT, acquiring healthcare facilities and leasing them to physician groups and healthcare systems [5].

Core Points - Global Medical REIT Inc. has announced a public offering of its Series B Cumulative Redeemable Preferred Stock, subject to market conditions [1][2] - The company plans to use the net proceeds from this offering for general corporate purposes, which may include funding new acquisitions and repaying existing debt [1] - The Series B Preferred Stock is expected to be listed on the New York Stock Exchange under the ticker symbol "GMRE-PrB" [2] Offering Details - The offering is being conducted under the company's shelf registration statement, which was declared effective by the SEC on April 4, 2024 [3] - The underwriters will have a 30-day option to purchase additional shares to cover over-allotments [1] - Book-running managers for the offering include Raymond James, BMO Capital Markets, Stifel, and Baird [2] Company Overview - Global Medical REIT Inc. operates as a net-lease medical REIT, acquiring healthcare facilities and leasing them to physician groups and healthcare systems [5]